← Eichor
Condition: Hemoglobin Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hemoglobin Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050The Association Between Preoperative HbA1c Levels and Postoperative Acute Kidney Injury in Isolated Coronary Artery Bypa
Phase N/A · 1 location(s) · Osman Sila Aydin · NCT07445997Cerebral Oxygen Metabolism in Children
NA · 1 location(s) · Washington University School of Medicine · NCT04157179A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510Oral Ketamine for Treatment of Vaso-Occlusive Pain
Phase 3 · 1 location(s) · Boston Children's Hospital · NCT05378555The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Phase N/A · 6 location(s) · Medical College of Wisconsin · NCT07227155Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
NA · 1 location(s) · Kazakh Academy of Nutrition · NCT07728669Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery
Phase N/A · 1 location(s) · Samsun University · NCT06857630PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
Phase 1 · 1 location(s) · Enrico Novelli · NCT04925492Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06364774A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Phase N/A · 6 location(s) · Genetix Biotherapeutics Inc. · NCT06271512Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
NA · 4 location(s) · Ohio State University · NCT06919224Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
NA · 1 location(s) · Nemours Children's Clinic · NCT05383911Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
Phase 1 · 1 location(s) · Daniel Bauer · NCT06647979Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Phase 1/Phase 2 · 1 location(s) · The Hospital for Sick Children · NCT05426252Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
EARLY_Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06313398Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT05810181Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Phase 3 · 13 location(s) · Novartis Pharmaceuticals · NCT06934967HPC Offered for PRESERVE Expansion
Phase N/A · 4 location(s) · Ossium Health, Inc. · NCT07145411Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
NA · 1 location(s) · Washington University School of Medicine · NCT06689800Connected Care for Type 2 Diabetes Self-Management
NA · 13 location(s) · Marche Region Regional Health Agency · NCT07149610Metabolic and Hemodynamic Reserve in Pediatric SCA
NA · 1 location(s) · Washington University School of Medicine · NCT04406818Non-Invasive Testing Device for Anaemia
Phase N/A · 1 location(s) · University of Oxford · NCT07361380Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carryi
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07432867Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult
Phase 3 · 32 location(s) · Novartis Pharmaceuticals · NCT06439082The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Phase 3 · 53 location(s) · Sanofi · NCT06975865Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semagluti
Phase N/A · 2 location(s) · Hospital Italiano de Buenos Aires · NCT07621419Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children
Phase 2 · 6 location(s) · Theravia · NCT06578507
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.